Home / Companies / Tyra Biosciences, Inc. / 28 May 2026
Tyra Biosciences, Inc.: meeting of 28 May 2026
Votes reported on Form N-PX, item by item
95 Form N-PX filers reported votes at the Tyra Biosciences, Inc. meeting of 28 May 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 80.6% of reported votes for; 37 filers withheld from or voted against at least one nominee.
528 vote records from 94 filers. 9 of the 93 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1 vote records from 1 filers. No filer marked a management recommendation, so no against-management figure is reported. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
176 vote records from 94 filers. 0 of the 93 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 3. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | For | For |
| American Century | For | For |
| Franklin Templeton | For | For |
| Invesco | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For |
| J.P. Morgan | For | For |
| Goldman Sachs | For | For |
| PGIM and Prudential | For | For |
| Jackson National funds | Abstain or withhold * | For |
| Northern Trust and FlexShares | Abstain or withhold * | For |
| SEI | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | For |
| Voya | Abstain or withhold * | For |
| Russell Investments | For | For |
| Nationwide | For | For |
| Victory Capital | For | For |
| Brighthouse Funds | For | For |
| Guggenheim and Rydex | For | For |
| Columbia Threadneedle | For | For |
| Principal | For | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| Transamerica | For | For |
| DWS | Abstain or withhold * | For |
| Janus Henderson | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Tyra Biosciences, Inc. meeting?
95 Form N-PX filers reported votes at the meeting of 28 May 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Tyra Biosciences, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Tyra Biosciences, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Tyra Biosciences, Inc. with a meeting date within three days of 28 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.